These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
48. Current Theories and Clinical Trial Evidence for Limiting Human Abdominal Aortic Aneurysm Growth. Yu J; Liu S; Huang J; Wang W Curr Drug Targets; 2018; 19(11):1302-1308. PubMed ID: 29141546 [TBL] [Abstract][Full Text] [Related]
49. Statins are associated with decreased mortality in abdominal, but not in thoracic aortic aneurysm patients undergoing endovascular repair: propensity score-adjusted analysis. Diehm N; Becker G; Katzen B; Benenati J; Kovacs M; Dick F Vasa; 2008 Aug; 37(3):241-9. PubMed ID: 18690591 [TBL] [Abstract][Full Text] [Related]
50. A clinical evaluation of statin pleiotropy: statins selectively and dose-dependently reduce vascular inflammation. van der Meij E; Koning GG; Vriens PW; Peeters MF; Meijer CA; Kortekaas KE; Dalman RL; van Bockel JH; Hanemaaijer R; Kooistra T; Kleemann R; Lindeman JH PLoS One; 2013; 8(1):e53882. PubMed ID: 23349755 [TBL] [Abstract][Full Text] [Related]
51. Efficient Suppression of Abdominal Aortic Aneurysm Expansion in Rats through Systemic Administration of Statin-Loaded Nanomedicine. Fukuhara N; Honda Y; Ukita N; Matsui M; Miura Y; Hoshina K Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33218045 [TBL] [Abstract][Full Text] [Related]
52. Pharmacological interventions to attenuate the expansion of abdominal aortic aneurysm (AAA) - a systematic review. Bergqvist D Eur J Vasc Endovasc Surg; 2011 May; 41(5):663-7. PubMed ID: 21330159 [TBL] [Abstract][Full Text] [Related]
53. Atorvastatin mediates increases in intralesional BAX and BAK expression in human end-stage abdominal aortic aneurysms. Schweitzer M; Mitmaker B; Obrand D; Sheiner N; Abraham C; Dostanic S; Chalifour LE Can J Physiol Pharmacol; 2009 Nov; 87(11):915-22. PubMed ID: 19935899 [TBL] [Abstract][Full Text] [Related]
54. Statin therapy for patients with abdominal aortic aneurysms. Diehm N Vasa; 2012 Jan; 41(1):3-4. PubMed ID: 22332284 [No Abstract] [Full Text] [Related]
55. Was the role of statins in slowing the progression of abdominal aortic aneurysms underestimated? Karrowni W; Miller FJ Am Heart J; 2011 May; 161(5):e29; author reply e31. PubMed ID: 21570503 [No Abstract] [Full Text] [Related]
56. Association of statins with aortic, peripheral, and visceral artery aneurysm development. Mansi IA; Frei CR; Halm EA; Mortensen EM Vascular; 2017 Aug; 25(4):372-381. PubMed ID: 28264180 [TBL] [Abstract][Full Text] [Related]
57. Inhibitory effect of statins on inflammation-related pathways in human abdominal aortic aneurysm tissue. Yoshimura K; Nagasawa A; Kudo J; Onoda M; Morikage N; Furutani A; Aoki H; Hamano K Int J Mol Sci; 2015 May; 16(5):11213-28. PubMed ID: 25993292 [TBL] [Abstract][Full Text] [Related]
58. A 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, cerivastatin, suppresses production of matrix metalloproteinase-9 in human abdominal aortic aneurysm wall. Nagashima H; Aoka Y; Sakomura Y; Sakuta A; Aomi S; Ishizuka N; Hagiwara N; Kawana M; Kasanuki H J Vasc Surg; 2002 Jul; 36(1):158-63. PubMed ID: 12096274 [TBL] [Abstract][Full Text] [Related]
59. A combination of statins and beta-blockers is independently associated with a reduction in the incidence of perioperative mortality and nonfatal myocardial infarction in patients undergoing abdominal aortic aneurysm surgery. Kertai MD; Boersma E; Westerhout CM; Klein J; Van Urk H; Bax JJ; Roelandt JR; Poldermans D Eur J Vasc Endovasc Surg; 2004 Oct; 28(4):343-52. PubMed ID: 15350554 [TBL] [Abstract][Full Text] [Related]
60. Statin use is associated with reduced all-cause mortality after endovascular abdominal aortic aneurysm repair. Leurs LJ; Visser P; Laheij RJ; Buth J; Harris PL; Blankensteijn JD Vascular; 2006; 14(1):1-8. PubMed ID: 16849016 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]